Trial reportEuropean radiology2026
Vascular attenuation and volumetric lung iodine density in dual-layer spectral CT pulmonary angiography: a randomized controlled trial comparing three contrast doses.
Trial report in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- What you don't see matters: dual-energy CT in emergency radiology.Japanese journal of radiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesTo evaluate vascular attenuation (VA) in conventional and low-energy virtual monoenergetic images (LEVMI), volumetric lung iodine density (VID) and quality of CT pulmonary angiography (CTPA) in dual-layer detector spectral CT using three iodinated contrast medium (ICM) administration protocols. MATERIALS AND
methodsA prospective randomized single-center study including patients with CTPA to rule out pulmonary embolism (PE) was performed. Examinations were randomized to one of three ICM administration protocols: A, 40 mL at 4 mL/s; B, 30 mL at 3 mL/s; and C, 20 mL of ICM diluted with 20 mL of saline at 4 mL/s. Two radiologists evaluated the presence of PE, VA in conventional images and LEVMI, lung VID, perfusion defects detection, and quality of Z-effective maps. Statistical comparisons were performed between protocols.
resultsFifty patients were randomized to each protocol. In conventional images, VA in pulmonary arteries was above 200 HU in more than 90% in protocols A and B, but only in 70% in protocol C. VA increased in LEVMI, with a minimum value of 269 HU. Differences in pulmonary VA with protocol C were statistically significant. At LEVMI, aortic attenuation was above 100 HU in most examinations. Protocol C presented the worst quality of iodine map and the lowest VID; however, it detected perfusion defects in all PE cases.
conclusionThe use of LEVMI provides diagnostic VA levels in pulmonary arteries in all the protocols, and a minimum aortic enhancement in most cases. Even the lowest ICM dose maintains diagnostic iodine maps, although with lower quality and VID. KEY POINTS: Question Do low doses of iodinated contrast medium for spectral CT pulmonary angiography achieve diagnostic vascular attenuation, and do they allow detection of perfusion defects in pulmonary embolism? Findings All three protocols achieved diagnostic pulmonary artery attenuation in low-energy virtual monoenergetic images and detected perfusion defects in all pulmonary embolism cases. Clinical relevance Spectral CT pulmonary angiography enables diagnostic pulmonary vascular enhancement and reliable perfusion defect detection with reduced contrast material doses, supporting safer and more efficient pulmonary embolism imaging protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.